View by Specialty

Trending

PC1124McDonald_Graphic_01_WEB
December 04, 2024
4 min read
Save

'We're listening': ABIM axes 'confusing' MOC program requirement

CHD/Prevention News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 23, 2024
3 min read
Save

GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval

GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval

Prescriptions for GLP-1 receptor agonists and SGLT2 inhibitors for patients with type 1 diabetes rose between 2010 and 2023 despite not being approved for that population, according to a research letter published in JAMA.

SPONSORED CONTENT
October 23, 2024
2 min watch
Save

VIDEO: Martha Gulati, MD, on practical solutions to improve CV outcomes in women

VIDEO: Martha Gulati, MD, on practical solutions to improve CV outcomes in women

BOSTON — In this Healio video exclusive, Martha Gulati, MD, MS, FACC, FAHA, FASPC, discusses her presentation at the Cardiometabolic Health Congress, “How to Improve Cardiovascular Outcomes in Women.”

Trending

PC1124McDonald_Graphic_01_WEB
December 04, 2024
4 min read
Save

'We're listening': ABIM axes 'confusing' MOC program requirement

SPONSORED CONTENT
October 23, 2024
2 min read
Save

Recurrent pregnancy loss may raise risk for hypertensive disorders among Black women

Recurrent pregnancy loss may raise risk for hypertensive disorders among Black women

DENVER — Black women with a history of recurrent pregnancy loss had a higher likelihood of developing hypertensive disorders of pregnancy, delivering offspring earlier and delivering offspring with lower birth weights, researchers reported.

SPONSORED CONTENT
October 22, 2024
3 min read
Save

Common PCOS treatments do not increase, decrease metabolic syndrome risk

Common PCOS treatments do not increase, decrease metabolic syndrome risk

DENVER — For women with polycystic ovary syndrome and overweight or obesity, neither oral contraceptive pills nor metformin altered the characteristic markers of metabolic syndrome, either alone or in combination, researchers reported.

SPONSORED CONTENT
October 21, 2024
3 min watch
Save

VIDEO: Pay attention to CV risk in young adults, measure Lp(a)

VIDEO: Pay attention to CV risk in young adults, measure Lp(a)

BOSTON — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, discusses her presentation at the Cardiometabolic Health Congress, “Primary Prevention of CVD: The Sooner the Better?”

SPONSORED CONTENT
October 21, 2024
1 min read
Save

Oral semaglutide prevents CV events in people with diabetes and heart disease, CKD

Oral semaglutide prevents CV events in people with diabetes and heart disease, CKD

Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.

SPONSORED CONTENT
October 21, 2024
3 min read
Save

New stroke primary prevention guideline calls for more screening of risk factors

New stroke primary prevention guideline calls for more screening of risk factors

The new guideline on primary prevention of stroke from the American Heart Association and American Stroke Association calls for more screening of risk factors such as high BP, high cholesterol and high blood glucose.

SPONSORED CONTENT
October 21, 2024
2 min read
Save

Bariatric surgery more cost-effective than GLP-1s in long term

Bariatric surgery more cost-effective than GLP-1s in long term

At current prices, bariatric surgery was more cost-effective than GLP-1 receptor agonists for treatment of obesity, researchers reported at the American College of Surgeons Clinical Congress.

SPONSORED CONTENT
October 18, 2024
3 min read
Save

Medication hesitancy when addressing patients’ obesity-related atherosclerotic risk

Medication hesitancy when addressing patients’ obesity-related atherosclerotic risk

BOSTON — In a survey, cardiology physicians expressed hesitancy to prescribe currently available obesity medications, preferring exercise and dietary interventions, but with little personalized tailoring for patients, researchers reported.

SPONSORED CONTENT
October 17, 2024
4 min read
Save

Speakers highlight 2024 regulatory moves in hypertension, lipid, diabetes therapies

Speakers highlight 2024 regulatory moves in hypertension, lipid, diabetes therapies

There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails